These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31955582)

  • 1. [The potential role of proteomic and glycomic biomarkers in chronic obstructive pulmonary disease diagnostics].
    Szabó M; Kun R; Hajba L; Koncz R; Guttman A; Csánky E
    Orv Hetil; 2020 Jan; 161(4):123-128. PubMed ID: 31955582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic and Glycomic Markers to Differentiate Lung Adenocarcinoma from COPD.
    Szabó M; Hajba L; Kun R; Guttman A; Csánky E
    Curr Med Chem; 2020; 27(20):3302-3313. PubMed ID: 30332938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease.
    Aydindogan E; Penque D; Zoidakis J
    Expert Rev Mol Diagn; 2019 Jan; 19(1):37-45. PubMed ID: 30560707
    [No Abstract]   [Full Text] [Related]  

  • 4. Multi-omics study on biomarker and pathway discovery of chronic obstructive pulmonary disease.
    Tang Y; Chen Z; Fang Z; Zhao J; Zhou Y; Tang C
    J Breath Res; 2021 Sep; 15(4):. PubMed ID: 34280912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD).
    Moon JY; Leitao Filho FS; Shahangian K; Takiguchi H; Sin DD
    Expert Rev Proteomics; 2018 Nov; 15(11):923-935. PubMed ID: 30362838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker discovery in asthma and COPD by proteomic approaches.
    Rossi R; De Palma A; Benazzi L; Riccio AM; Canonica GW; Mauri P
    Proteomics Clin Appl; 2014 Dec; 8(11-12):901-15. PubMed ID: 25186471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.
    Ghosh N; Dutta M; Singh B; Banerjee R; Bhattacharyya P; Chaudhury K
    Expert Rev Mol Diagn; 2016 Aug; 16(8):897-913. PubMed ID: 27267972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Biomarkers Based on Proteomic Technology in COPD: A Recent Review.
    Fang H; Liu Y; Yang Q; Han S; Zhang H
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1353-1365. PubMed ID: 37408604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
    Sin DD; Hollander Z; DeMarco ML; McManus BM; Ng RT
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1162-70. PubMed ID: 26176936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
    Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL
    J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers.
    Cazzola M; Puxeddu E; Ora J; Rogliani P
    Mol Diagn Ther; 2019 Oct; 23(5):603-614. PubMed ID: 31363933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From proteomics to prescription-the search for COPD biomarkers.
    Nicholas BL; O'Connor CD; Djukanovic R
    COPD; 2009 Aug; 6(4):298-303. PubMed ID: 19811390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.
    Casado B; Iadarola P; Luisetti M; Kussmann M
    Expert Rev Proteomics; 2008 Oct; 5(5):693-704. PubMed ID: 18937559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of glycomics as prognostic biomarkers in liver disease and liver transplantation.
    Verhelst X; Geerts A; Callewaert N; Van Vlierberghe H
    Acta Gastroenterol Belg; 2019; 82(2):309-313. PubMed ID: 31314193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease.
    Vogt HB; Rossing DR; Thomas DA
    S D Med; 2009; Spec No():30-7. PubMed ID: 19363891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in proteomic techniques for biomarker discovery in COPD.
    Casado B; Luisetti M; Iadarola P
    Expert Rev Clin Immunol; 2011 Jan; 7(1):111-23. PubMed ID: 21162654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for biomarkers of chronic obstructive pulmonary disease using proteomics: The current state.
    Cagnone M; Salvini R; Bardoni A; Fumagalli M; Iadarola P; Viglio S
    Electrophoresis; 2019 Jan; 40(1):151-164. PubMed ID: 30216498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized Alpha-1-Antitrypsin as a Potential Biomarker Associated with Onset and Severity of Chronic Obstructive Pulmonary Disease in Adult Population.
    Topic A; Milovanovic V; Lazic Z; Ivosevic A; Radojkovic D
    COPD; 2018 Oct; 15(5):472-478. PubMed ID: 30822244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of MMP-9 as a biomarker for detecting progression of chronic obstructive pulmonary disease.
    Abd El-Fatah MF; Ghazy MA; Mostafa MS; El-Attar MM; Osman A
    Biochem Cell Biol; 2015 Dec; 93(6):541-7. PubMed ID: 26291981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.